Applications of 2-Butyl-4-Spirocyclopentane-2-Imidazolin-5-One Hydrochloride in Industrial Manufacturing

As a specialized manufacturer of 2-Butyl-4-Spirocyclopentane-2-Imidazolin-5-One Hydrochloride, we supply this intermediate to select, high-value sectors within pharmaceutical synthesis, fine chemicals, agricultural actives, and advanced research applications. Each industrial scenario requires technical integration, complex compliance, and tailored formulation controls in accordance with strict regulatory standards.

1. Pharmaceutical Active Ingredient Synthesis

Major pharmaceutical companies use this molecule as a key intermediate in the multi-step synthesis of certain imidazoline-based compounds with anti-hypertensive or central nervous system indications. It serves as a building block in medicinal chemistry pipelines for research and eventual drug substance production, entering core condensation and cyclization phases. Stringent batch traceability, purity control, and documentation are mandatory throughout these processes.

Industry compliance standards

• Current Good Manufacturing Practice (cGMP, 21 CFR Parts 210 and 211, US FDA)
• ICH Q7: Good Manufacturing Practice for Active Pharmaceutical Ingredients
• European Pharmacopoeia (Ph. Eur.) reference standards during synthesis route qualification
• USP <1043> Ancillary Materials for Cell, Gene, and Tissue-Engineered Products (for innovative pipelines)

Typical usage ratio

• Standard input: 0.3–1.5 molar equivalents per target intermediate, based on reaction yield and batch size scale-up protocols
• Adjusted based on reaction conversion and downstream purification stage requirements

Downstream process integration

• Charged into batch reactor after initial solvent and base charging
• Participates in imidazolinone ring formation
• Directly impacts yield and purity of later imidazoline derivatives
• Residuals controlled via in-process analytical HPLC before next step

Final product types

• Pharmaceutical intermediates for development pipelines
• APIs for anti-hypertensive drugs
• Central nervous system investigational agents
• Reference compounds for analytical standards

2. Fine Chemicals for Agrochemical Synthesis

Selective agrochemical producers incorporate this compound as an intermediate in the synthesis of novel imidazoline-based herbicides. It undergoes further functionalization in pilot and full production settings, and its impurity profile must align with agrochemical registration requirements. The material typically enters post-condensation steps before analytic validation and final formulation as technical concentrates.

Industry compliance standards

• FAO/WHO Specifications (JMPR, FAO/WHO Code)
• ISO 9001:2015 for chemical manufacturing traceability
• OECD Principles of Good Laboratory Practice (GLP) for product development
• Regulation (EC) No 1107/2009 (EU Plant Protection Products Regulation)

Typical usage ratio

• Used at 0.5–2.2 molar equivalents per batch depending on desired chain length and functional group conversion
• Titrated to minimize side-reactions during functional group transfer reactions

Downstream process integration

• Added to agrochemical reactors following alkylation/cyclization base stages
• Cascades into further oxidation or substitution reactions
• Subjected to purge and trap impurity removal before technical-grade crystallization
• Monitored by GC-MS and HPLC for contaminant and yield analysis

Final product types

• Imidazolinone herbicide technical actives
• Agrochemical screening compounds for R&D
• Post-patent herbicide intermediates
• Standardized technical concentrates for downstream formulation

3. Functional Materials in Specialty Polymer Modification

Advanced material companies leverage this molecule as a modifier in specialty polymer synthesis, imparting selective ionic or hydrophobic properties to block copolymers and elastomers. Integration occurs in the monomer modification stage, allowing tailored performance in automotive, electronic, and filtration end-uses. All processes require documentation for REACH compliance and final application registration.

Industry compliance standards

• REACH Regulation (EC) No 1907/2006 (European Chemicals Agency)
• ISO 14001:2018 (Environmental Management for chemical producers)
• Customer-specific Purity and Migration Limits for material compatibility (e.g., automotive OEM specs)
• UL 94 or similar flame resistance protocols, depending on application

Typical usage ratio

• Supplied at 1–5% by weight in copolymer batches, as determined by target mechanical and surface properties
• Adjusted depending on required copolymer architecture and downstream crosslinking chemistry

Downstream process integration

• Pre-dissolved in monomer blend or fed via side stream dosing
• Initiates specific ring-opening and ion-exchange interactions during polymerization
• In-line viscosity and miscibility controls required throughout operation
• Follows direct isolation or pelletizing dependent on finished polymer grade

Final product types

• Ionic polymers for battery films
• Membrane separation layers for industrial filtration
• Elastomers for automotive gaskets
• Technical resins for electronics encapsulation

4. Building Block in Medicinal Chemistry Research

Contract research organizations and pharmaceutical R&D labs demand this raw material for rapid synthesis of novel heterocyclic scaffolds during exploratory medicinal chemistry. It features in fragment-based lead generation programs, early structure–activity relationship studies, and patent extension portfolios. Each application involves tightly controlled micro-scale synthesis, documentation for research reproducibility, and waste stream tracking for hazardous chemical disposal.

Industry compliance standards

• OECD GLP for laboratory-scale synthesis and purity records
• US EPA Resource Conservation and Recovery Act (RCRA) for chemical waste management
• Institutional Laboratory Safety Protocols (aligned with ACS guidelines)
• Material Transfer Agreements (MTAs) for collaborative research

Typical usage ratio

• Typically charged at 0.10–1.2 equivalents for parallel synthesis reactions, based on individual target molecule design
• Altered according to reactivity of other building blocks and desired final compound library size

Downstream process integration

• Dosed into micro-reactors or flask setups under inert atmosphere
• Involved in ring-closing steps and heteroatom substitutions
• Reaction monitored by TLC/LC-MS for structure confirmation
• Final products isolated by flash chromatography or preparative HPLC

Final product types

• Lead molecules for drug candidate screening
• Heterocyclic reference standards for SAR analysis
• Chemical probes for mechanistic pharmacology
• Custom fragments for early discovery libraries